Northern Trust Corp Werewolf Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 227,750 shares of HOWL stock, worth $362,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares

227,750

Previous 58,598 288.67%

Holding current value

$362,122

Previous $142,000 239.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.71 - $2.95 $289,249 - $498,998	169,152 Added 288.67%	227,750 $482,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $6.75 $23,624 - $68,148	10,096 Added 20.82%	58,598 $142,000
Q1 2024 May 14, 2024	SELL	$3.92 - $7.91 $4,492 - $9,064	-1,146 Reduced 2.31%	48,502 $314,000
Q4 2023 Feb 13, 2024	BUY	$1.78 - $4.15 $41,974 - $97,861	23,581 Added 90.46%	49,648 $191,000
Q2 2023 Aug 11, 2023	BUY	$2.31 - $3.65 $14,231 - $22,487	6,161 Added 30.95%	26,067 $79,000
Q1 2023 May 15, 2023	BUY	$1.98 - $4.3 $2,904 - $6,308	1,467 Added 7.96%	19,906 $51,000
Q4 2022 Feb 13, 2023	SELL	$1.53 - $4.73 $174 - $539	-114 Reduced 0.61%	18,439 $37,000
Q3 2022 Nov 14, 2022	BUY	$4.14 - $7.42 $19,602 - $35,133	4,735 Added 34.27%	18,553 $84,000
Q2 2022 Aug 12, 2022	SELL	$3.43 - $5.98 $621,687 - $1.08 Million	-181,250 Reduced 92.92%	13,818 $57,000
Q1 2022 May 13, 2022	SELL	$3.71 - $12.22 $18,538 - $61,063	-4,997 Reduced 2.5%	195,068 $859,000
Q4 2021 Feb 08, 2022	BUY	$11.48 - $17.65 $1.49 Million - $2.29 Million	129,661 Added 184.17%	200,065 $2.38 Million
Q3 2021 Nov 15, 2021	SELL	$13.89 - $20.31 $74,589 - $109,064	-5,370 Reduced 7.09%	70,404 $1.21 Million
Q2 2021 Aug 13, 2021	BUY	$11.6 - $17.44 $878,978 - $1.32 Million	75,774 New	75,774 $1.32 Million

Others Institutions Holding HOWL

# of Institutions

Shares Held

31.8M

Call Options Held

700

Put Options Held

500

View Full List

About Werewolf Therapeutics, Inc.

Ticker HOWL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,529,400
Market Cap $47M
Description
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...

More about HOWL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Werewolf Therapeutics, Inc. Transaction History